Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ketrosden Triasmitra Tbk. (KETR) vs Merck Tbk. (MERK) Price & Performance

Ketrosden Triasmitra Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Ketrosden Triasmitra Tbk. vs Merck Tbk. — how do they compare? Ketrosden Triasmitra Tbk. trades at Rp570 (market cap 1.56T, 10.53M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Ketrosden Triasmitra Tbk. and Merck Tbk. are close in size by market cap, and Ketrosden Triasmitra Tbk. is more actively traded (10.53M versus 29.1K). Which is the better fit depends on your goals.

KETRMERK
Market Cap
1.56T1.75T
Volume
10.53M29.1K
Lot
105.32K291
Turnover
5.98B113.37M
Average Price
567.883,895.98
Value
5.98B113.37M
Indicative Equilibrium Price
5703,890
Indicative Equilibrium Volume
8.62K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KETR
View details
MERK
View details

About Ketrosden Triasmitra Tbk.

PT Ketrosden Triasmitra Tbk was established base on Notarial Deed No.179 of Pudji Redjeki Irawati S.H., dated November 25, 1994.

Read more on KETR

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK